News
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...
21hon MSN
Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish ...
The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...
3d
The Print on MSNWhy Trump’s executive order lowering prescription drug prices won’t rattle Indian pharma industryThe order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal tariff on pharmaceutical products.
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...
The S&P 500 rose for a fourth straight day on Thursday, riding a relief rally in response to the U.S. and China agreeing to ...
President Donald Trump imposed a minimum tariff of 10% on almost all countries, before later suspending the measures ...
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
7d
Zacks Investment Research on MSNDrug Stocks Recover as Trump's Order Proves Not as Bad as FearedShares of key drugmakers like Eli Lilly LLY, Pfizer PFE, Merck MRK, AbbVie ABBV, Gilead, Bristol-Myers, Amgen AMGN and several other U.S. pharmaceutical stocks were in the green at market close on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results